Effects of angiotensin II on the cerebral circulation: Role of oxidative stress

Frontiers in Physiology

Volumn 3 JAN, Issue , 2013, Pages

  De Silva, T Michael ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cerebral arteries; Cerebral blood flow; Endothelium; NADPH oxidase; Neurovascular coupling; Nitric oxide

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC OXIDE; PROTEIN KINASE C; PROTEIN P22; PROTEIN P47; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

BINDING SITE; BLOOD BRAIN BARRIER; BRAIN ARTERY; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFORMATIONAL TRANSITION; CYTOPLASM; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HYPERTENSION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOMOTOR REFLEX;

EID: 84874562000     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00484     Document Type: Review

References (124)

1. Aghajanian, A., Wittchen, E. S., Campbell, S. L., and Burridge, K. (2009). Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS ONE 4:e8045. doi: 8010.1371/journal.pone.0008045
2. Ago, T., Kitazono, T., Kurado, J., Kumai, Y., Kamouchi, M., Ooboshi, H., et al. (2005). NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36, 1040-1046.
3. Ahnstedt, H., Saveland, H., Nilsson, O., and Edvinsson, L. (2011). Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway. BMC Neurosci. 12:5. doi: 10.1186/1471-2202-12-5
4. Ambasta, R. K., Kumar, P., Griendling, K. K., Schmidt, H. H., Busse, R., and Brandes, R. P. (2004). Direct inter-action of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279, 45935-45941.
5. Amberg, G. C., Earley, S., and Glapa, S. A. (2010). Local regulation of arterial L-type calcium channels by reactive oxygen species. Circ. Res. 107, 1002-1010.
6. 1 recep-tor blockade reverses pathologi-cal hypertrophy and inflammation in brain microvessels of sponta-neously hypertensive rats. Stroke 35, 1726-1731.
7. Appelros, P., Stegmayr, B., and Terent, A. (2009). Sex differences in stroke epidemiology: a systematic review. Stroke 40, 1082-1090.
8. Banfi, B., Clark, R., Steger, K.,and Krause, K. (2003). Two novel pro-teins activate superoxide genera-tion by the NADPH oxidase NOX1. J. Biol. Chem. 278, 3510-3513.
9. Basset, O., Deffert, C., Foti, M., Bedard, K., Jaquet, V., Ogier-Denis, E., et al. (2009). NADPH oxidase 1 deficiency alters caveolin phospho-rylation and angiotensin II-receptor localization in vascular smooth muscle. Antioxid. Redox Signal. 11, 2371-2384.
10. Baumbach, G., and Heistad, D. (1989). Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13, 968-972.
11. Baumbach, G. L., Sigmund, C. D., and Faraci, F. M. (2003). Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 41, 50-55.
12. Beason-Held, L. L., Moghekar, A., Zonderman, A. B., Kraut, M. A., and Resnick, S. M. (2007). Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 38, 1766-1773.
13. Bedard, K., and Krause, K.-H. (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313.
14. Bevan, R., Dodge, J., Nichols, P., Poseno, T., Vijayakumaran, E., Wellman, T., et al. (1998). Responsiveness of human infant cerebral arteries to sympathetic nerve stimulation and vasoactive agents. Pediatr. Res. 44, 730-739.
15. 2+ sensitization in pulmonary vascular smooth muscle through superoxide-dependent stimulation of RhoA. Am. J. Physiol. Lung Cell Mol. Physiol. 298, L232-L242.
16. Capone, C., Anrather, J., Milner, T. A., and Iadecola, C. (2009). Estrous cycle-dependent neu-rovascular dysfunction induced by angiotensin II in the mouse neocortex. Hypertension 54, 302-307.
17. Capone, C., Faraco, G., Anrather, J., Zhou, P., and Iadecola, C. (2010). Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension 55, 911-917.
18. Capone, C., Faraco, G., Park, L., Cao, X., Davisson, R. L., and Iadecola, C. (2011). The cerebrovascular dys-function induced by slow pressor doses of angiotensin-II precedes the development of hypertension. Am. J. Physiol. Heart Circ. Physiol. 300, H397-H407.
19. Capone, C., Faraco, G., Peterson, J. R., Coleman, C., Anrather, J., Milner, T. A., et al. (2012). Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. J. Neurosci. 32, 4878-4886.
20. Chan, S., and Baumbach, G. (2009). Nox2 deficiency pre-vents angiotensin II-induced hypertrophy and inward remodel-ing in cerebral arterioles (Abstract). FASEB J. 23, 11.
21. Chen, K., Kirber, M.T., Xiao, H., Yang, Y., and Keaney, J. F. Jr. (2008). Regulation of ROS signal transduc-tion by NADPH oxidase 4 localiza-tion. J. Cell Biol. 181, 1129-1139.
22. Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., and Lambeth, J. D. (2001). Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269, 131-140.
23. Choi, H., Leto, T. L., Hunyady, L., Catt, K. J., Bae, Y. S., and Rhee, S. G. (2008). Mechanism of angiotensin II-induced superoxide produc-tion in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase. J. Biol. Chem. 283, 255-267.
24. Chrissobolis, S., Banfi, B., Sobey, C. G., and Faraci, F. M. (2012). Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. J. Appl. Physiol. 113, 184-191.
25. Chrissobolis, S., and Faraci, F. M. (2008). The role of oxidative stress and NADPH oxidase in cerebrovas-cular disease. Trends Mol. Med. 14, 495-502.
26. Chrissobolis, S., and Faraci, F. M. (2010). Sex differences in protec-tion against angiotensin II-induced endothelial dysfunction by man-ganese superoxide dismutase in the cerebral circulation. Hypertension 55, 905-910.
27. Cipolla, M. J. (2007). Cerebrovascular function in pregnancy and eclamp-sia. Hypertension 50, 14-24.
28. Dai, W., Lopez, O.L., Carmichael, O. T., Becker, J. T., Kuller, L. H., and Gach, H. M. (2008). Abnormal regional cerebral blood flow in cognitively normal elderly sub-jects with hypertension. Stroke 39, 349-354.
29. Deleo, F. R., Yu, L., Burritt, J. B., Loetterle, L. R., Bond, C. W., Jesaitis, A. J., et al. (1995). Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc. Natl. Acad. Sci. U.S.A. 92, 7110-7114.
30. De Silva, T. M., Broughton, B. R. S., Drummond, G.R., Sobey, C. G., and Miller, A. A. (2009). Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species. Stroke 40, 1091-1097.
31. Didion, S., and Faraci, F. (2002). Effects of NADH and NADPH on superox-ide levels and cerebral vascular tone. Am. J. Physiol. HeartCirc. Physiol. 282, H688-H695.
32. Didion, S., Hathaway, C., and Faraci, F. (2001). Superoxide levels and function of cerebral blood ves-sels after inhibition of CuZn-SOD. Am. J. Physiol. HeartCirc. Physiol. 281, H1697-H1703.
33. Dikalova, A. E., Gongora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S., and Griendling, K. K. (2010). Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am. J. Physiol. HeartCirc. Physiol. 299, H673-H679.
34. Dirnagl, U., Niwa, K., Lindauer, U.,and Villringer, A. (1994). Coupling of cerebral blood flow to neuronal acti-vation: role of adenosine and nitric oxide. Am.J.Physiol.HeartCirc. Physiol. 267, H296-H301.
35. Drummond, G. R., Selemidis, S., Griendling, K. K., and Sobey, C. G. (2011). Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10, 453-471.
36. Efimova, I. Y., Efimova, N. Y., Triss, S. V., and Lishmanov, Y. B. (2008). Brain perfusion and cognitive function changes in hyperten-sive patients. Hypertens. Res. 31, 673-678.
37. Fan, L. M., Teng, L., and Li, J.-M. (2009). Knockout of p47phox uncovers a critical role of p40phox in reactive oxygen species produc-tion in microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 29, 1651-1656.
38. Faraci, F. M. (2006). Hydrogen perox-ide: watery fuel for change in vas-cular biology. Arterioscler. Thromb. Vasc. Biol. 26, 1931-1933.
39. Faraci, F. M. (2011). Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 300, H1566-H1582.
40. Faraci, F. M., Lamping, K. G., Modrick, M. L., Ryan, M. J., Sigmund, C. D., and Didion, S. P. (2006). Cerebral vascular effects of angiotensin II: new insights from genetic mod-els. J. Cereb. Blood Flow Metab. 26, 449-455.
41. Filosa, J. A., Bonev, A. D., Straub, S. V., Meredith, A. L., Wilkerson, M. K., Aldrich, R. W., et al. (2006). Local potassium signaling couples neu-ronal activity to vasodilation in the brain. Nat. Neurosci. 9, 1397-1403.
42. Fleegal-Demotta, M. A., Doghu, S., and Banks, W. A. (2009). Angiotensin II modulates BBB permeability via activation of the AT1 receptor in brain endothelial cells. J. Cereb. Blood Flow Metab. 29, 640-647.
43. Fontayne, A., Dang, P. M., Gougerot-Pocidalo, M. A., and El-Benna, J. (2002). Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on bind-ing to p22phox and on NADPH oxidase activation. Biochemistry 41, 7743-7750.
44. Fujii, K., Heistad, D. D., and Faraci, F. M. (1991). Flow-mediated dilata-tion of the basilar artery in vivo. Circ. Res. 69, 697-705.
45. Fujii, K., Heistad, D. D., and Faraci, F. M. (1992). Effect of diabetes mellitus on flow-mediated and endothelium-dependent dilatation of the rat basilar artery. Stroke 23, 1494-1498.
46. Geiszt, M. S., Kopp, J. B., Varnai, P. T., and Leto, T. L. (2000). Identification of Renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. U.S.A. 97, 8010-8014.
47. 2+ channel activity in angiotensin-hypertension. Hypertension 41, 1124-1130.
48. Girouard, H., Lessard, A., Capone, C., Milner, T. A., and Iadecola, C. (2008). The neurovascular dysfunc-tion induced by angiotensin II in the mouse neocortex is sexually dimor-phic. Am.J.Physiol.HeartCirc. Physiol. 294, H156-H163.
49. Girouard, H., Park, L., Anrather, J., Zhou, P., and Iadecola, C. (2006). Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through Nox-2-derived radicals. Arterioscler. Thromb. Vasc. Biol. 26, 826-832.
50. Girouard, H., Park, L., Anrather, J., Zhou, P., and Iadecola, C. (2007). Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 27, 303-309.
51. Groemping, Y., Lapouge, K., Smerdon, S. J., and Rittinger, K. (2003). Molecular basis of phosphorylation-induced activa-tion of the NADPH oxidase. Cell 113, 343-355.
52. Guillot, F. L., and Audus, K. L. (1991). Angiotensin peptide regu-lation of bovine brain microvessel endothelial cell monolayer perme-ability. J. Cardiovasc. Pharmacol. 18, 212-218.
53. Hilenski, L. L., Clempus, R. E., Quinn, M. T., Lambeth, J. D., and Griendling, K. K. (2004). Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth mus-cle cells. Arterioscler. Thromb. Vasc. Biol. 24, 677-683.
54. Hilgers, R. H. P., and Webb, R. C. (2005). Molecular aspects of arte-rial smooth muscle contraction: focus on rho. Exp. Biol. Med. 230, 829-835.
55. Iadecola, C., and Davisson, R. L. (2008). Hypertension and cerebrovascular dysfunction. Cell Metab. 7, 476-484.
56. Iadecola, C., and Nedergaard, M. (2007). Glial regulation of the cerebral microvasculature. Nat. Neurosci. 10, 1369-1376.
57. Iadecola, C., Li, J., Ebner, T. J., and Xu, X. (1995). Nitric oxide con-tributes to functional hyperemia in cerebellar cortex. Am. J. Physiol. Regul. Integr. Comp. Physiol. 268, R1153-R1162.
58. Jackman, K. A., Miller, A. A., Drummond, G.R.,andSobey, C. G. (2009). Importance of NOX1 for angiotensin II-induced cere-brovascular superoxide production and cortical infarct volume follow-ing ischemic stroke. Brain Res. 1286, 215-220.
59. 2+ sensitization in pul-monary vascular smooth muscle following chronic hypoxia. Am. J. Physiol. Lung Cell Mol. Physiol. 295, L515-L529.
60. Jin, L., Ying, Z., and Webb, R. C. (2004). Activation of Rho/Rho kinase sig-naling pathway by reactive oxy-gen species in rat aorta. Am. J. Physiol. Heart Circ. Physiol. 287, H1495-H1500.
61. Kawahara, T., Ritsick, D., Cheng, G., and Lambeth, J. D. (2005). Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1-and Nox2-dependent reac-tive oxygen generation. J. Biol. Chem. 280, 31859-31869.
62. Kazama, K., Anrather, J., Zhou, P., Girouard, H., Frys, K., Milner, T. A., et al. (2004). Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ. Res. 95, 1019-1026.
63. Kazama, K., Wang, G., Frys, K., Anrather, J., and Iadecola, C. (2003). Angiotensin II attenu-ates functional hyperemia in the mouse somatosensory cortex. Am. J. Physiol. Heart Circ. Physiol. 285, H1890-H1899.
64. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., et al. (1996). Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248.
65. Kimura, Y., Kitagawa, K., Oku, N., Kajimoto, K., Kato, H., Tanaka, M., et al. (2010). Blood pressure low-ering with valsartan is associated with maintenance of cerebral blood flow and cerebral perfusion reserve in hypertensive patients with cere-bral small vessel disease. J. Stroke Cerebrovasc. Dis. 19, 85-91.
66. Kinugawa, S., Huang, H., Wang, Z., Kaminski, P. M., Wolin, M. S., and Hintze, T. H. (2005). A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenu-ates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ. Res. 96, 355-362.
67. Kitayama, J., Faraci, F.M., Lentz, S. R., and Heistad, D. D. (2007). Cerebral vascular dysfunction dur-ing hypercholesterolemia. Stroke 38, 2136-2141.
68. Kitayama, J., Yi, C., Faraci, F. M., and Heistad, D. D. (2006). Modulation of dilator responses of cerebral arte-rioles by extracellular superoxide dismutase. Stroke 37, 2802-2806.
69. Kivipelto, M., Helkala, E. L., Laakso, M. P., Hanninen, T., Hallikainen, M., Alhainen, K., et al. (2001). Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322, 1447-1451.
70. Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M. E., Jones, E., Mittal, M., et al. (2010). Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegener-ation. PLoS Biol. 8:e1000479. doi: 10.1371/journal.pbio.1000479
71. Kuroda, J., Nakagawa, K., Yamasaki, T., Nakamura, K.-I., Takeya, R., Kuribayashi, F., et al. (2005). The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cell 10, 1139-1151.
72. Landmesser, U., Dikalov, S., Price, S. R., Mccann, L., Fukai, T., Holland, S. M., et al. (2003). Oxidation of tetrahydrobiopterin leads to uncou-pling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209.
73. Leung, T., Manser, E., Tan, L., and Lim, L. (1995). A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translo-cates the kinase to peripheral membranes. J. Biol. Chem. 270, 29051-29054.
74. Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R.,and Collaboration, P. S. (2002). Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913.
75. Li, J. M., and Shah, A. M. (2002). Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothe-lial cells. J. Biol. Chem. 277, 19952-19960.
76. Lipsitz, L. A., Gagnon, M., Vyas, M., Iloputaife, I., Kiely, D. K., Sorond, F., et al. (2005). Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension 45, 216-221.
77. Liu, X., Li, C., Falck, J. R., Roman, R. J., Harder, D. R., and Koehler, R. C. (2008). Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex. Am. J. Physiol. Heart Circ. Physiol. 295, H619-H631.
78. Lyle, A. N., Deshpande, N. N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., et al. (2009). Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascu-lar smooth muscle cells. Cir. Res. 105, 249-259.
79. Manabe, K., Shirahase, H., Usui, H., Kurahashi, K., and Fujiwara, M. (1989). Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J. Pharmacol. Exp. Ther. 251, 317-320.
80. Martyn, K., Frederick, L., Von Loehneysen, K., Dinauer, M., and Knaus, U. (2006). Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell. Signal. 18, 69-82.
81. Meno, J.R., Crum, A.V., and Winn, H. R. (2001). Effect of adenosine receptor blockade on pial arteriolar dilation during sciatic nerve stim-ulation. Am.J.Physiol.HeartCirc. Physiol. 281, H2018-H2027.
82. Miller, A. A., Budzyn, K., and Sobey, C. G. (2010). Vascular dysfunction in cerebrovascular disease: mecha-nisms and therapeutic intervention. Clin. Sci. (Lond.) 119, 1-17.
83. Miller, A.A., Drummond, G.R., De Silva, T. M., Mast, A. E., Hickey, H., Williams, J. P., et al. (2009). NADPH oxidase activity is higher in cere-bral versus systemic arteries of four animal species: role of Nox2. Am. J. Physiol. Heart Circ. Physiol. 296, H220-H225.
84. Miller, A.A., Drummond, G.R.,and Sobey, C. G. (2006). Novel isoforms of NADPH-oxidase in cerebral vas-cular control. Pharmacol. Ther. 111, 928-948.
85. Miller, A. A., Drummond, G. R., Mast, A.E., Schmidt, H.H.H.W.,and Sobey, C. G. (2007a). Effect of gender on NADPH-oxidase activ-ity, expression, and function in the cerebral circulation: role of estro-gen. Stroke 38, 2142-2149.
86. Miller, F. J., Filali, M., Huss, G. J., Stanic, B., Chamseddine, A., Barna, T. J., et al. (2007b). Cytokine activation of nuclear factor κB in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ. Res. 101, 663-671.
87. Miller, A., Drummond, G., Schmidt, H., and Sobey, C. (2005). NADPH oxidase activity and function are profoundly greater in cerebral ver-sus systemic arteries. Circ. Res. 97, 1055-1062.
88. Modrick, M. L., Didion, S. P., Lynch, C.M., Dayal, S., Lentz, S.R.,and Faraci, F. M. (2009). Role of hydro-gen peroxide and the impact of glu-tathione peroxidase-1 in regulation of cerebral vascular tone. J. Cereb. Blood Flow Metab. 29, 1130-1137.
89. Muller, M., Van Der Graaf, Y., Visseren, F. L., Mali, W. P. T. M., Geerlings, M. I., and For The Smart Study Group. (2012). Hypertension and longi-tudinal changes in cerebral blood flow: the SMART-MR study. Ann. Neurol. 71, 825-833.
90. Nagata, R., Kawabe, K., and Ikeda, K. (2010). Olmesartan, an angiotensin II receptor blocker, restores cere-bral hypoperfusion in elderly patients with hypertension. J. Stroke Cerebrovasc. Dis. 19, 236-240.
91. Naqvi, T. Z., and Hyuhn, H. K. (2009). Cerebrovascular mental stress reac-tivity is impaired in hypertension. Cardiovasc. Ultrasound 7:32. doi: 10.1186/1476-7120-7-32
92. Narayanan, D., Xi, Q., Pfeffer, L. M., and Jaggar, J. H. (2010). Mitochondria control functional CaV1.2 expression in smooth muscle cells of cerebral arteries. Circ. Res. 107, 631-641.
93. Naveri, L., Stromberg, C.,andSaavedra, J. M. (1994). Angiotensin II AT1 receptor mediated contraction of the perfused rat cerebral artery. Neuroreport 5, 2278-2280.
94. Nisimoto, Y., Motalebi, S., Han, C.-H., and Lambeth, J. D. (1999). The p67 phox activation domain regulates electron flow from NADPH to flavin in flavocytochrome b558. J. Biol. Chem. 274, 22999-23005.
95. Niwa, K., Araki, E., Morham, S. G., Ross, M. E., and Iadecola, C. (2000). Cyclooxygenase-2 con-tributes to functional hyperemia in whisker-barrel cortex. J. Neurosci. 20, 763-770.
96. Niwa, K., Haensel, C., Ross, M. E., and Iadecola, C. (2001). Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ. Res. 88, 600-608.
97. Nobuhisa, I., Takeya, R., Ogura, K., Ueno, N., Kohda, D., Inagaki, F., et al. (2006). Activation of the superoxide-producing phagocyte NADPH oxidase requires co-operation between the tandem SH3 domains of p47phox in recognition of a polyproline type II helix and an adjacent alpha-helix of p22phox. Biochem. J. 396, 183-192.
98. O'Donnell, M.J., Xavier, D., Liu, L., Zhang, H., Chin, S.L., Rao-Melacini, P., et al. (2010). Risk fac-tors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE Study): a case-control study. Lancet 376, 112-123.
99. Oku, N., Kitagawa, K., Imaizumi, M., Takasawa, M., Piao, R., Kimura, Y., et al. (2005). Hemodynamic influ-ences of losartan on the brain in hypertensive patients. Hypertens. Res. 28, 43-49.
100. Paravicini, T., Chrissobolis, S., Drummond, G.,andSobey, C. (2004). Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilata-tion to NADPH in vivo. Stroke 35, 584-589.
101. Paravicini, T., Miller, A., Drummond, G., and Sobey, C. (2006). Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J. Cereb. Blood Flow Metab. 26, 836-845.
102. Park, L., Anrather, J., Zhou, P., Frys, K., Wang, G., and Iadecola, C. (2004). Exogenous NADPH increases cerebral blood flow through NADPH oxidase-dependent and -independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 24, 1860-1865.
103. Prencipe, M., Ferretti, C., Casini, A., Santini, M., Giubilei, F., and Culasso, F. (1997). Stroke, dis-ability and dementia: results of a population survey. Stroke 28, 531-536.
104. Rodrigues, S. F., and Granger, D. N. (2011). Cerebral microvas-cular inflammation in DOCA salt-induced hypertension: role of angiotensin II and mitochondrial superoxide. J. Cereb. Blood Flow Metab. 32, 368-375.
105. Roger, V.L., Go, A.S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., et al. (2011). Heart disease and stroke statistics-2011 update. Circulation 123, e18-e209.
106. Santhanam, A. V. R., D'Uscio, L. V., Smith, L. A., and Katusic, Z. S. (2012). Uncoupling of eNOS causes superoxide anion production and impairs NO signaling in the cere-bral microvessels of hph-1 mice. J. Neurochem. 122, 1211-1218.
107. Sarfstein, R., Gorzalczany, Y., Mizrahi, A., Berdichevsky, Y., Molshanski-Mor, S., Weinbaum, C., et al. (2004). Dual role of rac in the assem-bly of NADPH oxidase, tethering to the membrane and activation of p67phox. J. Biol. Chem. 279, 16007-16016.
108. Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., et al. (2012). Nox4 Is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110, 1217-1225.
109. Selemidis, S., Sobey, C. G., Wingler, K., Schmidt, H. H., and Drummond, G. R. (2008). NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacologi-cal inhibition. Pharmacol. Ther. 120, 254-291.
110. Sipkens, J. A., Hahn, N., Van Den Brand, C. S., Meischl, C., Cillessen, S. A., Smith, D. E., et al. (2011). Homocysteine-Induced Apoptosis in Endothelial Cells Coincides With Nuclear NOX2 and Peri-nuclear NOX4 Activity. Cell Biochem. Biophys. doi: 10.1007/s12013-011-9297-y. [Epub ahead of print].
111. Stenman, E., and Edvinsson, L. (2004). Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats. Stroke 35, 970-974.
112. Taylor, W.R., Jones, D.T.,and Segal, A. W. (1993). A structural model for the nucleotide binding domains of the flavocytochrome b-245 beta-chain. Protein Sci. 2, 1675-1685.
113. Thomson, L., Trujillo, M., Telleri, R., and Radi, R. (1995). Kinetics of cytochrome c2+ oxidation by peroxynitrite: implications for superoxide measurements in nitric oxide-producing biological sys-tems. Arch. Biochem. Biophys. 319, 491-497.
114. Toda, N., Ayaziki, K., and Okamura, T. (1990). Modifications by endoge-nous prostaglandins of angiotensin II-induced contractions in dog and monkey cerebral and mesenteric arteries. J. Pharmacol. Exp. Ther. 252, 374-379.
115. Van Buul, J. D., Fernandez-Borja, M., Anthony, E. C., and Hordijk, P. L. (2005). Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid. Redox Signal. 7, 308-317.
116. Vasquez-Vivar, J., Kalyanaraman, B., Martã¡Sek, P., Hogg, N., Masters, B. S. S., Karoui, H., et al. (1998). Superoxide generation by endothelial nitric oxide syn-thase: the influence of cofactors. Proc. Natl. Acad. Sci. U.S.A. 95, 9220-9225.
117. Vasquez-Vivar, J., Martasek, P., Hogg, N., Masters, B.S., Pritchard, K.A. Jr., and Kalyanaraman, B. (1997). Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36, 11293-11297.
118. Vincent, J.-M., Kwan, Y. W., Lung Chan, S., Perrin-Sarrado, C., Atkinson, J., and Chillon, J.-M. (2005). Constrictor and dilator effects of angiotensin II on cerebral arterioles. Stroke 36, 2691-2695.
119. Vital, S. A., Terao, S., Nagai, M., and Granger, D. N. (2010). Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation 17, 641-649.
120. Waldstein, S. R., Lefkowitz, D. M., Siegel, E. L., Rosenberger, W. F., Spencer, R. J., Tankard, C. F., et al. (2010). Reduced cerebral blood flow in older men with higher levels of blood pressure. J. Hypertens. 28, 993-998.
121. Whalley, E.T., Amure, Y.O.,and Lye, R. H. (1987). Analysis of the mechanism of action of bradykinin on human basilar artery in vitro. Naunyn Schmiedebergs Arch. Pharmacol. 335, 433-437.
122. Whalley, E. T., Paul, K. S., and Gulati, O. P. (1985). Anti-spasmogenic effects of bencianol (ZY15051) on human cerebral arteries in vitro. Cephalalgia 5, 217-221.
123. Zhang, A. Y., Yi, F., Zhang, G., Gulbins, E., and Li, P.-L. (2006). Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 47, 74-80.
124. Zhang, M., Mao, Y., Ramirez, S. H., Tuma, R.F.,andChabrashvili, T. (2010). Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171, 852-858